Federal Register #DEA-1751

Bulk Manufacturer Registration Application for Controlled Substances by Curia New York Inc

This opportunity involves the Drug Enforcement Administration (DEA) reviewing Curia New York Inc's application to become a bulk manufacturer of controlled substances. - Government Buyer: - Drug Enforcement Administration (DEA), U.S. Department of Justice - Applicant/OEM: - Curia New York Inc - Products/Controlled Substances Requested: - Gamma Hydroxybutyric Acid (drug code 2010, Schedule I) - Marihuana (drug code 7360, Schedule I; synthetic manufacturing only) - Tetrahydrocannabinols (drug code 7370, Schedule I; synthetic manufacturing only) - Amphetamine (drug code 1100, Schedule II) - Lisdexamfetamine (drug code 1205, Schedule II) - Methylphenidate (drug code 1724, Schedule II) - Pentobarbital (drug code 2270, Schedule II) - 4-Anilino-N-phenethyl-4-piperidine (ANPP, drug code 8333, Schedule II) - Notable Requirements: - Marihuana and Tetrahydrocannabinols must be manufactured synthetically; no other activities authorized for these drug codes - Substances are intended for product development and distribution - Public comments and objections are requested regarding the registration - No specific purchase quantities or part numbers beyond drug codes are provided

Description

Curia New York Inc has applied to be registered as a bulk manufacturer of basic classes of controlled substances. The company plans to manufacture these controlled substances as bulk active pharmaceutical ingredients for use in product development and distribution to its customers. Specifically, for Marihuana and Tetrahydrocannabinols, the company plans to manufacture these drugs synthetically. No other activities for these drug codes are authorized for this registration. Comments and objections to the issuance of the proposed registration may be submitted electronically by October 26, 2026.

View original listing